Table 3.
Period prevalence of selected STIs and other conditions among females attending GUM clinics in England in 2011 by sex worker status
| Female sex workers | Other female attendees | Association with being a female sex worker | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Period prevalence (%) | Diagnosed/tested* (n/N) | Period prevalence (%) | Diagnosed/tested* (n/N) | OR (unadjusted) | 95% CI | p Value | OR (adjusted†) | 95% CI | p Value | |
| Chlamydia‡ | 10.1 | 257/2534 | 8.5 | 47 336/556 686 | 1.28 | 1.12 to 1.46 | <0.001 | 1.93 | 1.61 to 2.33 | <0.001 |
| Gonorrhoea | 2.7 | 68/2534 | 1.0 | 5756/553 960 | 2.76 | 2.16 to 3.54 | <0.001 | 2.75 | 1.87 to 4.04 | <0.001 |
| Syphilis | 0.1 | 3/2380 | 0.1 | 285/466 248 | 2.97 | 0.95 to 9.33 | 0.06 | 2.55 | 0.59 to 11.03 | 0.21 |
| HIV§ | 0.2 | 5/2405 | 0.2 | 895/443 740 | 1.16 | 0.48 to 2.80 | 0.74 | 0.74 | 0.18 to 3.04 | 0.68 |
| Herpes | 2.3 | 62/2704 | 2.8 | 19 165/696 941 | 0.83 | 0.65 to 1.07 | 0.15 | 0.91 | 0.63 to 1.32 | 0.63 |
| Genital warts | 2.8 | 76/2704 | 5.0 | 34 676/696 941 | 0.55 | 0.44 to 0.69 | <0.001 | 1.07 | 0.79 to 1.45 | 0.68 |
| Hepatitis B | 0.6 | 16/2704 | 0.1 | 429/696 941 | 9.66 | 5.86 to 15.94 | <0.001 | 1.63 | 0.51 to 5.24 | 0.82 |
| Hepatitis C | 0.2 | 6/2704 | 0.04 | 260/696 941 | 5.96 | 2.65 to 13.40 | <0.001 | 1.68 | 0.39 to 7.27 | 0.49 |
| Trichomoniasis | 0.9 | 24/2704 | 0.8 | 5459/696 941 | 1.13 | 0.76 to 1.70 | 0.54 | 1.64 | 0.96 to 2.82 | 0.07 |
| Scabies | 0.1 | 3/2704 | 0.03 | 207/696 941 | 3.74 | 1.20 to 11.69 | 0.02 | 8.18 | 1.81 to 36.89 | 0.01 |
| Molluscum contagiosum | 0.5 | 14/2704 | 0.5 | 3585/696 941 | 1.01 | 0.60 to 1.70 | 0.98 | 1.51 | 0.79 to 2.86 | 0.21 |
| Bacterial vaginosis | 25.6 | 691/2704 | 12.7 | 88 238/696 941 | 2.37 | 2.17 to 2.58 | <0.001 | 2.30 | 2.04 to 2.59 | <0.001 |
| Candidosis | 16.6 | 450/2704 | 7.5 | 52 612/696 941 | 2.45 | 2.21 to 2.71 | <0.001 | 1.92 | 1.68 to 2.19 | <0.001 |
| Urinary tract infection | 7.8 | 212/2704 | 2.2 | 14 984/696 941 | 3.87 | 3.36 to 4.46 | <0.001 | 2.29 | 1.90 to 2.75 | <0.001 |
| Pelvic inflammatory disease | 10.6 | 286/2704 | 2.3 | 16 204/696 941 | 4.97 | 4.39 to 5.62 | <0.001 | 4.21 | 3.58 to 4.95 | <0.001 |
| Other conditions | 19.6 | 530/2704 | 9.2 | 64 402/696 941 | 1.77 | 1.61 to 1.95 | <0.001 | 1.37 | 1.20 to 1.56 | <0.001 |
| Abnormal cervical cell cytology | 32.9 | 111/337 | 16.3 | 1716/10 520 | 17.34 | 14.26 to 21.09 | <0.001 | 8.66 | 6.60 to 11.37 | <0.001 |
Significant differences (p Value <0.05) highlighted in bold.
*For chlamydia, gonorrhoea, syphilis and HIV, N=women with a recorded test for the STI of interest; for abnormal cell cytology, N=women with a recorded smear test; and for all other STIs/conditions without a SHAPPT code for the relevant diagnostic test/investigation, N=all women.
†Adjusting for age, ethnicity, migrant status, sexual orientation, location (inner London, outer London or outside London), deprivation of postcode of residence and chlamydia and/or gonorrhoea diagnosis.
‡Code suffixes to identify oral or rectal chlamydia infections were introduced to GUMCAD in 2011. However, as the use of these suffixes was not consistent across all clinics in 2011, the data presented here includes all chlamydia infections. In future, it will be possible to provide information on the site of infection.
§New HIV diagnoses in 2011.
GUM, genitourinary medicine; GUMCAD, Genitourinary Medicine Clinic Activity Dataset; STI, sexually transmitted infection.